ID   SNT-13
AC   CVCL_A674
SY   SNT13
DR   Cosmic; 2390217
DR   GEO; GSM349852
DR   GEO; GSM349853
DR   GEO; GSM472007
DR   Wikidata; Q54955073
RX   PubMed=12780797;
RX   PubMed=20132662;
RX   PubMed=21052088;
RX   PubMed=25586472;
RX   PubMed=36094314;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126348; Chronic active EBV disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=12780797; DOI=10.1046/j.1365-2141.2003.04359.x;
RA   Zhang Y., Nagata H., Ikeuchi T., Mukai H., Oyoshi M.K., Demachi A.,
RA   Morio T., Wakiguchi H., Kimura N., Shimizu N., Yamamoto K.;
RT   "Common cytological and cytogenetic features of Epstein-Barr virus
RT   (EBV)-positive natural killer (NK) cells and cell lines derived from
RT   patients with nasal T/NK-cell lymphomas, chronic active EBV infection
RT   and hydroa vacciniforme-like eruptions.";
RL   Br. J. Haematol. 121:805-814(2003).
//
RX   PubMed=20132662; DOI=10.1179/102453310X12583347009450;
RA   Zhang Y., Ohyashiki J.H., Shimizu N., Ohyashiki K.;
RT   "Aberrant expression of NK cell receptors in Epstein-Barr
RT   virus-positive gammadelta T-cell lymphoproliferative disorders.";
RL   Hematology 15:43-47(2010).
//
RX   PubMed=21052088; DOI=10.1038/leu.2010.255;
RA   Iqbal J., Weisenburger D.D., Chowdhury A., Tsai M.-Y., Srivastava G.,
RA   Greiner T.C., Kucuk C., Deffenbacher K.E., Vose J.M., Smith L., Au W.Y.,
RA   Nakamura S., Seto M., Delabie J., Berger F., Loong F., Ko Y.-H.,
RA   Sng I., Liu X., Loughran T.P. Jr., Armitage J.O., Chan W.-C.;
RT   "Natural killer cell lymphoma shares strikingly similar molecular
RT   features with a group of non-hepatosplenic gammadelta T-cell lymphoma
RT   and is highly sensitive to a novel aurora kinase A inhibitor in
RT   vitro.";
RG   International Peripheral T-cell Lymphoma Project;
RL   Leukemia 25:348-358(2011).
//
RX   PubMed=25586472; DOI=10.1038/ncomms7025; PMCID=PMC7743911;
RA   Kucuk C., Jiang B., Hu X.-Z., Zhang W.-Y., Chan J.K.C., Xiao W.-M.,
RA   Lack N., Alkan C., Williams J.C., Avery K.N., Kavak P., Scuto A.,
RA   Sen E., Gaulard P., Staudt L.M., Iqbal J., Zhang W.-W., Cornish A.,
RA   Gong Q., Yang Q.-P., Sun H., d'Amore F.A., Leppa S., Liu W.-P., Fu K.,
RA   de Leval L., McKeithan T.W., Chan W.-C.;
RT   "Activating mutations of STAT5B and STAT3 in lymphomas derived from
RT   gammadelta-T or NK cells.";
RL   Nat. Commun. 6:6025.1-6025.12(2015).
//
RX   PubMed=36094314; DOI=10.1128/JVI.00739-22; PMCID=PMC9517713;
RA   Ding W.-Y., Wang C., Narita Y., Wang H.-B., Leong M.M.L., Huang A.,
RA   Liao Y.-F., Liu X.-F., Okuno Y., Kimura H., Gewurz B.E., Teng M.-X.,
RA   Jin S.-L., Sato Y., Zhao B.;
RT   "The Epstein-Barr virus enhancer interaction landscapes in
RT   virus-associated cancer cell lines.";
RL   J. Virol. 96:e00739.22.1-e00739.22.11(2022).
//